National Cancer Institute (NCI): all 3,554 studies

Page 33 of 36. Open to participants first (334), then studies with results posted, then the rest; newest registration first within each.

• Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With IrinotecanCompletedNCT00016978Phase 2
• Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast CancerCompletedNCT00016549Phase 2
• CCI-779 in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00016328Phase 2
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00016302Not applicable
• Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00016289Phase 2
• Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast CancerTerminatedNCT00016276Phase 3
• Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate CancerCompletedNCT00016107Phase 2
• S0108 Bevacizumab in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00016094Phase 2
• Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute LeukemiaCompletedNCT00016016Phase 1/2
• Thalidomide in Treating Patients With Myelodysplastic SyndromeCompletedNCT00015990Phase 2
• Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaTerminatedNCT00015912Phase 2
• STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00015834Phase 1/2
• Thalidomide in Treating Patients With MyelofibrosisCompletedNCT00015821Phase 2
• Karenitecin in Treating Patients With Recurrent Malignant GliomaCompletedNCT00014521Phase 1
• Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00014170Phase 2
• Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic MalignanciesCompletedNCT00013533Early Phase 1
• Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid CancerCompletedNCT00012376Phase 1
• 7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid TumorsTerminatedNCT00012194Phase 1
• Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or LymphomasCompletedNCT00012181Phase 1
• PS-341 and Radiation to Treat Advanced Cancer of the Head and NeckCompletedNCT00011778Phase 1
• Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid TumorsCompletedNCT00011414Phase 1
• Benzoylphenylurea in Treating Patients With Advanced CancerTerminatedNCT00010205Phase 1
• Rituximab Plus Interleukin-2 in Treating Patients With Hematologic CancerCompletedNCT00010192Phase 1
• Thalidomide With or Without Fludarabine in Treating Patients With Hematologic CancerTerminatedNCT00009984Phase 2
• Fenretinide in Treating Patients With Recurrent Small Cell Lung CancerCompletedNCT00009971Phase 2
• Vaccine Therapy With or Without Sargramostim in Treating Patients With CancerTerminatedNCT00009958Phase 1
• SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous TreatmentTerminatedNCT00009919Phase 2
• Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal TumorTerminatedNCT00009906Phase 3
• Arsenic Trioxide in Treating Patients With Urothelial CancerCompletedNCT00009867Phase 2
• Natural History of Patients With Brain and Spinal Cord TumorsCompletedNCT00009035
• Monoclonal Antibody Therapy in Treating Patients With Recurrent or Refractory LymphomaCompletedNCT00007956Phase 1
• Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid TumorsCompletedNCT00007917Phase 1
• Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT00007878Phase 1
• Immunotoxin Therapy in Treating Patients With Advanced CancerCompletedNCT00006981Phase 1
• Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00006942Phase 2
• Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00006929Phase 2
• Bortezomib in Treating Patients With Recurrent GliomaTerminatedNCT00006773Phase 1
• Capravirine to Treat Children With HIV InfectionCompletedNCT00006519Phase 1
• Late Effects of Treatment for Sarcomas in ChildrenCompletedNCT00006515
• Carboxyamidotriazole in Treating Patients With Metastatic Kidney CancerCompletedNCT00006486Phase 2
• Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00006473Phase 2
• Phenylbutyrate to Treat Children With Progressive or Recurrent Brain TumorsCompletedNCT00006450Phase 2
• Study of Plexiform Neurofibromas in Neurofibromatosis Type 1CompletedNCT00006435
• Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle StudyCompletedNCT00006425
• Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up StudyCompletedNCT00006421
• Lung Screening StudyCompletedNCT00006382Not applicable
• Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT00006364Phase 2
• Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00006363Phase 3
• Micellar Paclitaxel to Treat Severe PsoriasisCompletedNCT00006276Phase 2
• Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant MelanomaCompletedNCT00006243Not applicable
• BMS-214662 in Treating Patients With Advanced Solid TumorsCompletedNCT00006242Phase 1
• Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast CancerCompletedNCT00006228Phase 2
• Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaCompletedNCT00006226Phase 2
• EMD 121974 in Treating Patients With HIV-Related Kaposi's SarcomaTerminatedNCT00006222Phase 1
• BMS-247550 in Treating Patients With Advanced CancersCompletedNCT00006221Phase 1
• BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid LeukemiaCompletedNCT00006213Phase 1
• Effects of Potent Antiretroviral Therapy on Kaposi s SarcomaCompletedNCT00006171
• SU5416 and Carboplatin to Treat Ovarian CancerCompletedNCT00006155Phase 1
• Celecoxib in Treating Patients With Bladder CancerCompletedNCT00006124Phase 2/3
• ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck CancerWithdrawnNCT00006106Phase 1
• Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00006102Phase 2
• Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the RectumCompletedNCT00006094Phase 1/2
• Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial CancerCompletedNCT00006089Phase 2
• Oxaliplatin to Treat Advanced Cancers With Liver DysfunctionCompletedNCT00006062Phase 1
• Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by SurgeryCompletedNCT00006016Phase 2
• Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal CancerTerminatedNCT00006015Phase 2
• SU5416 in Treating Patients With Malignant MesotheliomaCompletedNCT00006014Phase 2
• Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically RemovedCompletedNCT00006006Phase 2
• SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously TreatedTerminatedNCT00006003Phase 2
• SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal CancerTerminatedNCT00006001Phase 2
• 506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell LymphomaTerminatedNCT00005982Phase 2
• Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent GliomaCompletedNCT00005976Phase 2
• BMS-214662 in Treating Patients With Solid TumorsCompletedNCT00005973Phase 1
• Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast CancerCompletedNCT00005970Phase 3
• Tipifarnib in Treating Patients With Advanced Hematologic CancerCompletedNCT00005967Phase 1
• O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic MelanomaCompletedNCT00005961Phase 2
• 506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell LymphomaTerminatedNCT00005950Phase 2
• Vaccine Plus Interleukin-2 in Treating Patients With Advanced MelanomaCompletedNCT00005949Phase 2
• Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial TherapyCompletedNCT00005942Phase 1/2
• Gemcitabine, Herceptin and Radiation to Treat Cancer of the PancreasCompletedNCT00005926Phase 2
• PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate CancerCompletedNCT00005916Phase 2
• Voriconazole to Prevent Systemic Fungal Infections in ChildrenCompletedNCT00005912Phase 1
• SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue SarcomasCompletedNCT00005862Phase 2
• Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma MultiformeTerminatedNCT00005856Phase 1/2
• Tipifarnib in Treating Patients With Myelodysplastic SyndromesCompletedNCT00005845Phase 1
• R115777 in Treating Patients Who Have Metastatic Pancreatic CancerCompletedNCT00005843Phase 2
• Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerCompletedNCT00005842Phase 1
• Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By SurgeryCompletedNCT00005838Phase 3
• Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract CancerCompletedNCT00005831Phase 2
• SU5416 and Irinotecan in Treating Patients With Advanced Colorectal CancerCompletedNCT00005818Phase 1/2
• Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast CancerCompletedNCT00005817Phase 2
• Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous TreatmentCompletedNCT00005811Phase 2
• Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial NeoplasiaTerminatedNCT00005808Phase 1
• Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or LeukemiaTerminatedNCT00005786Not applicable
• Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual MolesCompletedNCT00005781
• The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive DiseasesCompletedNCT00005660
• Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced CancerTerminatedNCT00005655Phase 1
• Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid TumorsCompletedNCT00005604Phase 1
• Gemcitabine in Treating Children With Refractory Solid TumorsCompletedNCT00005577Phase 1
• Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With NeuroblastomaCompletedNCT00005576Phase 1

← National Cancer Institute (NCI) overview and focus areas